Ezatiostat
Alternative Names: Ezatiostat HCl; Ezatiostat hydrochloride; Telintra; TLK-199Latest Information Update: 25 Aug 2015
Price :
$50 *
At a glance
- Originator Telik
- Developer MabVax Therapeutics; Telik
- Class Antineoplastics; Small molecules
- Mechanism of Action Glutathione S-transferase pi inhibitors; JNK mitogen-activated protein kinase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Myelodysplastic syndromes; Neutropenia
Most Recent Events
- 25 Aug 2015 No recent reports of development identified - Phase-I for Myelodysplastic syndromes (Combination therapy) in USA (PO)
- 25 Aug 2015 No recent reports of development identified - Phase-II for Myelodysplastic syndromes (Monotherapy) in USA (PO)
- 25 Aug 2015 No recent reports of development identified - Phase-II for Neutropenia in USA (PO)